Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Total Non-current Assets
All assets not expected to be converted to cash within one year.
Total Non-current Assets history
Currency unavailable · from the balance sheet
No Total Non-current Assets data reported for this period type.
Total Non-current Assets vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $140.36M USD | -37.3% | +7.2% | 32.4% | |
| Mar 2026 | $91.56M USD | +588.3% | +176.1% | 21.9% | |
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | $12.9M USD | +16.4% | +245.9% | 2.6% |
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | $8.39M USD | +36.8% | +57.2% | 3.2% |
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | $4.41M USD | -1.3% | +1044.9% | 1.1% |
| Mar 2026 | $3.04M USD | -88.2% | -70.3% | 1.1% | |
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | $443K USD | -76.5% | -76.3% | 0.3% |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | -1.3% | +57.2% | 2.6% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.